Glycoprotein Storage Disease
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
1
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Hydrops fetalis (type II, congenital)
|
phenotype |
|
Finding
|
1
|
|
0.300 |
strong |
1.000 |
1 |
|
2001 |
2001 |
Urinary excretion of sialylated oligosaccharides
|
phenotype |
|
Finding
|
1
|
|
0.100 |
None |
|
0 |
|
|
|
Increased urinary O-linked sialopeptides
|
phenotype |
|
Finding
|
2
|
|
0.100 |
None |
|
0 |
|
|
|
Sialidase deficiency
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
3
|
23
|
0.720 |
strong |
1.000 |
12 |
23
|
1996 |
2014 |
Neuraminidase 1 deficiency
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
3
|
4
|
0.540 |
strong |
1.000 |
6 |
2
|
2004 |
2019 |
Lipomucopolysaccharidosis
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
3
|
4
|
0.410 |
None |
1.000 |
2 |
4
|
2003 |
2017 |
Metastatic Squamous Cell Carcinoma of the Oropharynx
|
disease |
|
Neoplastic Process
|
4
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Sialidosis, type 2
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
5
|
2
|
0.310 |
None |
1.000 |
1 |
2
|
2004 |
2004 |
Bone-marrow foam cells
|
phenotype |
|
Finding
|
5
|
2
|
0.100 |
None |
|
0 |
|
|
|
Myoclonus, Action
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Sign or Symptom
|
6
|
1
|
0.020 |
None |
1.000 |
2 |
|
2009 |
2014 |
beta-Galactosidase Deficiency
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Nervous System Diseases
|
Disease or Syndrome
|
6
|
|
0.010 |
None |
1.000 |
1 |
|
1984 |
1984 |
Paget's Disease, Mammary
|
disease |
Neoplasms
|
Neoplastic Process
|
8
|
|
0.010 |
None |
1.000 |
1 |
|
1990 |
1990 |
Vacuolated lymphocytes
|
phenotype |
|
Finding
|
8
|
|
0.100 |
None |
|
0 |
|
|
|
Vacuolated Lymphocyte Count
|
phenotype |
|
Laboratory Procedure
|
8
|
|
0.100 |
None |
|
0 |
|
|
|
Anatomic Stage II Breast Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
9
|
1
|
0.010 |
None |
1.000 |
1 |
|
1988 |
1988 |
Prognostic Stage II Breast Cancer AJCC v8
|
disease |
|
Neoplastic Process
|
9
|
1
|
0.010 |
None |
1.000 |
1 |
|
1988 |
1988 |
Facial edema
|
disease |
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Skin and Connective Tissue Diseases; Male Urogenital Diseases; Immune System Diseases; Cardiovascular Diseases
|
Pathologic Function
|
9
|
1
|
0.100 |
None |
|
0 |
|
|
|
Cherry red spot of the macula
|
phenotype |
|
Finding
|
9
|
15
|
0.100 |
None |
|
0 |
|
|
|
Type I Mucolipidosis
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
10
|
4
|
0.700 |
strong |
1.000 |
28 |
4
|
1984 |
2020 |
Breast cancer stage II
|
disease |
|
Neoplastic Process
|
10
|
1
|
0.010 |
None |
1.000 |
1 |
|
1988 |
1988 |
Ewing's sarcoma of bone
|
disease |
Neoplasms
|
Neoplastic Process
|
10
|
|
0.010 |
None |
1.000 |
1 |
|
2002 |
2002 |
Isolated thrombocytopenia
|
disease |
|
Disease or Syndrome
|
10
|
9
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Stage II Breast Cancer AJCC v6 and v7
|
disease |
|
Neoplastic Process
|
11
|
1
|
0.010 |
None |
1.000 |
1 |
|
1988 |
1988 |
Skin Diseases, Vascular
|
group |
Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
11
|
2
|
0.100 |
None |
|
0 |
|
|
|